Willingness to Pay for Breast Cancer Screening: A Systematic Review

https://doi.org/10.22146/jmpf.94440

Anietta Indri Ramadhani(1), Susi Ari Kristina(2*), Vo Quang Trung(3)

(1) Master Student of Pharmacy Management, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta
(2) Department of Pharmaceutics, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta
(3) Pham Ngoc Thach University of Medicine, Ho Chi Minh City
(*) Corresponding Author

Abstract


Background: Women's breast cancer was identified as the primary contributor to global cancer cases. This condition puts a significant economic burden on both society and the healthcare system, with the highest expenses related to medical treatment costs.

Objectives: The study aims to review the willingness to pay (WTP) for breast cancer screening and the factors influencing it.

Methods: Four databases (Scopus, PubMed, ProQuest, and Google Scholar) were used to search related articles that mentioned the WTP for breast cancer screening. Preferred Reporting Items for Systematic Reviews (PRISMA) guideline was used to execute this systematic review study. Finally, 11 articles were included in this study. The quality of reviewed studies was assessed using a JBI cross-sectional study and a JBI quasi-experimental study.

Results: The study found that the WTP value for breast cancer screening varied from $1 to $500 in Iran, Malaysia, Singapore, the US, and Canada. Most studies explained that willingness to pay and willingness to take breast cancer screening were affected by sociodemographic aspects such as family history of ovarian or breast cancer, income status, education status, age, and marital status.

Conclusion: Governmental authorities should consider the implementation of a breast cancer screening program or explore cost-sharing mechanisms for breast screening, to mitigate the incidence of breast cancer.


Keywords


breast cancer screening; mammography; willingness to pay; WTP

Full Text:

PDF


References

  1. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-249. doi:10.3322/caac.21660
  2. Arnold M, Morgan E, Rumgay H, et al. Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast. 2022;66(August):15-23. doi:10.1016/j.breast.2022.08.010
  3. Jalali FS, Keshavar K, Seif M, Akrami M, Jafari A, Ravangard R. Economic burden of breast cancer: a case of Southern Iran. Cost Eff Resour Alloc. 2023;21(1):1-8. doi:10.1186/s12962-023-00470-8
  4. Daroudi R, Sari AA, Nahvijou A, Kalaghchi B, Najafi M, Zendehdel K. The economic burden of breast cancer in Iran. Iran J Public Health. 2015;44(9):1225-1233.
  5. Meshkani Z, Moradi N, Aboutorabi A, Jafari A, Shams R. Subjective valuation of Iranian women for screening for gene-related diseases: a case of breast cancer. BMC Public Health. 2023;23(1). doi:10.1186/s12889-023-15568-0
  6. W H O. 789241 548397. WHO pOsitiOn Pap Mammogr Screen. Published online 2014.
  7. Nelson HD, Fu R, Cantor A, Pappas M, Daeges M, Humphrey L. Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 U.S. Preventive Services Task Force Recommendation. Ann Intern Med. 2016;164(4):244-255. doi:10.7326/M15-0969
  8. Ren W, Chen M, Qiao Y, Zhao F. Global guidelines for breast cancer screening: A systematic review. Breast. 2022;64(January):85-99. doi:10.1016/j.breast.2022.04.003
  9. Pace LE, Keating NL. A systematic assessment of benefits and risks to guide breast cancer screening decisions. Jama. 2014;311(13):1327-1335. doi:10.1001/jama.2014.1398
  10. Schmidt J, Bijmolt THA. Accurately measuring willingness to pay for consumer goods: a meta-analysis of the hypothetical bias. J Acad Mark Sci. 2020;48(3):499-518. doi:10.1007/s11747-019-00666-6
  11. Karimabadi A, Pourahmadi E, Bafandeh Imandoust S, Nikoukar A, Aryafar M. Knowledge, Practice, Preferences and Willingness-to-Pay for Mammographic Screening Tests among Iranian Women: A Contingent Valuation Method. Asian Pac J Cancer Prev. 2022;23(4):1207-1213. doi:10.31557/APJCP.2022.23.4.1207
  12. Aizuddin AN, Ramdzan AR, Omar SAS, et al. Genetic testing for cancer risk: Is the community willing to pay for it? Int J Environ Res Public Health. 2021;18(16). doi:10.3390/ijerph18168752
  13. Blouin-Bougie J, Amara N, Bouchard K, Simard J, Dorval M. Disentangling the determinants of interest and willingness-to-pay for breast cancer susceptibility testing in the general population: a cross-sectional Web-based survey among women of Québec (Canada). BMJ Open. 2018;8(2):e016662. doi:10.1136/bmjopen-2017-016662
  14. Sabermahani A, Mohammad Taghizade S, Goodarzi R. A Comparative Study on Willingness to Pay for Breast Cancer and Osteoporosis Screening in Kerman, Southeastern Iran. Iran J Public Health. 2017;46(5):693-698.
  15. Khaliq W, Harris CM, Landis R, Bridges JFP, Wright SM. Hospitalized women’s willingness to pay for an inpatient screening mammogram. Ann Fam Med. 2014;12(6):556-558. doi:10.1370/afm.1694
  16. Miron-Shatz T, Hanoch Y, Doniger GM, Omer ZB, Ozanne EM. Subjective but not objective numeracy influences willingness to pay for BRCA1/2 genetic testing. Judgm Decis Mak. 2014;9(2):152-158. doi:10.1017/s1930297500005519
  17. Teo CT, Yeo YWS, Lee SC. Screening mammography behavior and barriers in Singaporean Asian women. Am J Health Behav. 2013;37(5):667-682. doi:10.5993/AJHB.37.5.11
  18. Nosratnejad S, Rahmani S, Yousefi M, Moeeni M. Women’s Willingness to Pay for Mammography Screening under Two Medical Information Scenarios. Eur J Cancer Care (Engl). 2023;2023:1-5. doi:10.1155/2023/3732383
  19. Guo F, Hirth JM, Fuchs EL, et al. Knowledge, Attitudes, Willingness to Pay, and Patient Preferences About Genetic Testing and Subsequent Risk Management for Cancer Prevention. J cancer Educ Off J Am Assoc Cancer Educ. 2022;37(2):362-369. doi:10.1007/s13187-020-01823-0
  20. Wong XY, Groothuis-Oudshoorn CG, Tan CS, et al. Women’s preferences, willingness-to-pay, and predicted uptake for single-nucleotide polymorphism gene testing to guide personalized breast cancer screening strategies: a discrete choice experiment. Patient Prefer Adherence. 2018;12:1837-1852. doi:10.2147/PPA.S171348
  21. American Cancer Society. Breast Cancer Early Detection and Diagnosis American Cancer Society. Am Cancer Soc. Published online 2022:1-55. https://www.cancer.org/content/dam/CRC/PDF/Public/8579.00.pdf
  22. Duffy SW, Tabár L, Yen AMF, et al. Mammography screening reduces rates of advanced and fatal breast cancers: Results in 549,091 women. Cancer. 2020;126(13):2971-2979. doi:10.1002/cncr.32859
  23. Yong ASJ, Lim YH, Cheong MWL, Hamzah E, Teoh SL. Willingness-to-pay for cancer treatment and outcome: a systematic review. Eur J Heal Econ. 2022;23(6):1037-1057. doi:10.1007/s10198-021-01407-9
  24. Lalla D, Carlton R, Santos E, Bramley T, Souza AD. Willingness to pay to avoid metastatic breast cancer treatment side effects : results from a conjoint analysis. Published online 2014:1-7.
  25. Oh D youn, Crawford B, Kim S bae, et al. Evaluation of the willingness-to-pay for cancer treatment in Korean metastatic breast cancer patients : A multicenter , cross-sectional study. Published online 2012:1-10. doi:10.1111/j.1743-7563.2012.01546.x
  26. Farabi H, Rezapour A, Moradi N, Aghamir SMK, Koohpayehzadeh J. Men’s willingness to pay for prostate cancer screening: a systematic review. Syst Rev. 2020;9(1):1-10. doi:10.1186/s13643-020-01522-3
  27. Tavakoli B, Feizi A, Zamani-Alavijeh F, Shahnazi H. Factors influencing breast cancer screening practices among women worldwide: a systematic review of observational and qualitative studies. BMC Womens Health. 2024;24(1):1-16. doi:10.1186/s12905-024-03096-x
  28. Al Blooshi, Noora Ali ; Al Mazrouei, Ruqayya Saaed ; Al Razooqi, Hind Nasser ; Darwish, Ebtihal Ahmad ; Al Fahim, Maha Mohamed ; Khan FB. Knowledge, attitudes, and practices related to breast cancer screening among women visiting primary care centers in Abu Dhabi. 2019;13(2):36-38.



DOI: https://doi.org/10.22146/jmpf.94440

Article Metrics

Abstract views : 1208 | views : 928

Refbacks

  • There are currently no refbacks.


Copyright (c) 2025 JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice)

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

©Jurnal Manajemen dan Pelayanan Farmasi
Faculty of Pharmacy
Universitas Gadjah Mada
Creative Commons License
View My Stats